Complete resection rate at interval debulking surgery after bevacizumab containing neoadjuvant therapy: primary objective of the ANTHALYA trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreComplete resection rate at interval debulking surgery after bevacizumab containing neoadjuvant therapy: primary objective of the ANTHALYA trial
Type de publicationJournal Article
Year of Publication2016
AuteursRouzier R., Gouy S., Selle F., Lambaudie E., Guyon F., Fourchotte V., Pomel C., Colombo P-E., Kalbacher E., Martin-Francoise S., Fauvet R., Follana P., Lesoin A., Lecuru F., Ghazi Y., Dupin J., Chereau E., Zohar S., Cottu P., Joly F.
JournalANNALS OF ONCOLOGY
Volume27
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1093/annonc/mdw374.7